Quantitative Systematic Strategies LLC Gilead Sciences, Inc. Transaction History

Quantitative Systematic Strategies LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$60.0 - $68.46 $1.5 Million - $1.71 Million	-24,948 Reduced 62.68%	14,852 $960,000
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $2.25 Million - $2.57 Million	39,800 New	39,800 $2.32 Million
Q2 2019 Jul 25, 2019	SELL	$61.87 - $69.38 $894,949 - $1 Million	-14,465 Closed	0 $0
Q1 2019 Apr 15, 2019	SELL	$62.53 - $70.05 $684,390 - $766,697	-10,945 Reduced 43.07%	14,465 $940,000
Q4 2018 Feb 12, 2019	SELL	$60.54 - $79.0 $54,667 - $71,337	-903 Reduced 3.43%	25,410 $1.59 Million
Q3 2018 Nov 14, 2018	BUY	$71.28 - $78.92 $1.16 Million - $1.29 Million	16,319 Added 163.29%	26,313 $2.03 Million
Q2 2018 Aug 07, 2018	BUY	$64.88 - $75.68 $648,410 - $756,345	9,994 New	9,994 $708,000
Q1 2018 May 04, 2018	SELL	$72.84 - $88.8 $462,534 - $563,880	-6,350 Closed	0 $0
Q4 2017 Feb 01, 2018	BUY	$71.15 - $83.52 $451,802 - $530,352	6,350	6,350 $455,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Quantitative Systematic Strategies LLC, based on Form 13F filings with the SEC.

Stay updated on Quantitative Systematic Strategies LLC with notifications on news.